Literature DB >> 18216021

Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.

Sean R Stowell1, Connie M Arthur, Padmaja Mehta, Kristen A Slanina, Ola Blixt, Hakon Leffler, David F Smith, Richard D Cummings.   

Abstract

Human galectins have functionally divergent roles, although most of the members of the galectin family bind weakly to the simple disaccharide lactose (Galbeta1-4Glc). To assess the specificity of galectin-glycan interactions in more detail, we explored the binding of several important galectins (Gal-1, Gal-2, and Gal-3) using a dose-response approach toward a glycan microarray containing hundreds of structurally diverse glycans, and we compared these results to binding determinants on cells. All three galectins exhibited differences in glycan binding characteristics. On both the microarray and on cells, Gal-2 and Gal-3 exhibited higher binding than Gal-1 to fucose-containing A and B blood group antigens. Gal-2 exhibited significantly reduced binding to all sialylated glycans, whereas Gal-1 bound alpha2-3- but not alpha2-6-sialylated glycans, and Gal-3 bound to some glycans terminating in either alpha2-3- or alpha2-6-sialic acid. The effects of sialylation on Gal-1, Gal-2, and Gal-3 binding to cells also reflected differences in cellular sensitivity to Gal-1-, Gal-2-, and Gal-3-induced phosphatidylserine exposure. Each galectin exhibited higher binding for glycans with poly-N-acetyllactosamine (poly(LacNAc)) sequences (Galbeta1-4GlcNAc)(n) when compared with N-acetyllactosamine (LacNAc) glycans (Galbeta1-4GlcNAc). However, only Gal-3 bound internal LacNAc within poly(LacNAc). These results demonstrate that each of these galectins mechanistically differ in their binding to glycans on the microarrays and that these differences are reflected in the determinants required for cell binding and signaling. The specific glycan recognition by each galectin underscores the basis for differences in their biological activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216021      PMCID: PMC2442294          DOI: 10.1074/jbc.M709545200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 3.  The role of galectins in the initiation, amplification and resolution of the inflammatory response.

Authors:  N Rubinstein; J M Ilarregui; M A Toscano; G A Rabinovich
Journal:  Tissue Antigens       Date:  2004-07

4.  Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation.

Authors:  Andreas Sturm; Martin Lensch; Sabine André; Herbert Kaltner; Bertram Wiedenmann; Stefan Rosewicz; Axel U Dignass; Hans-Joachim Gabius
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

5.  Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.

Authors:  Nisar Ahmad; Hans-J Gabius; Subramanian Sabesan; Stefan Oscarson; C Fred Brewer
Journal:  Glycobiology       Date:  2004-05-17       Impact factor: 4.313

6.  Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes.

Authors:  Nisar Ahmad; Hans-J Gabius; Sabine André; Herbert Kaltner; Subramanian Sabesan; René Roy; Bingcan Liu; Frank Macaluso; C Fred Brewer
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

7.  CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.

Authors:  Tomoharu Fukumori; Yukinori Takenaka; Tadashi Yoshii; Hyeong-Reh Choi Kim; Victor Hogan; Hidenori Inohara; Susumu Kagawa; Avraham Raz
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

8.  Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides.

Authors:  Sean R Stowell; Marcelo Dias-Baruffi; Leena Penttilä; Ossi Renkonen; A Kwame Nyame; Richard D Cummings
Journal:  Glycobiology       Date:  2003-10-23       Impact factor: 4.313

Review 9.  Thermodynamic binding studies of galectin-1, -3 and -7.

Authors:  C Fred Brewer
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

10.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro.

Authors:  Kouichi Ozaki; Katsumi Inoue; Hiroshi Sato; Aritoshi Iida; Yozo Ohnishi; Akihiro Sekine; Hideyuki Sato; Keita Odashiro; Masakiyo Nobuyoshi; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nature       Date:  2004-05-06       Impact factor: 49.962

View more
  166 in total

1.  ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.

Authors:  Zhongyu Liu; Amanda F Swindall; Robert A Kesterson; Trenton R Schoeb; Daniel C Bullard; Susan L Bellis
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 2.  The hypothesis on function of glycosphingolipids and ABO blood groups revisited.

Authors:  Jerzy Kościelak
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

Review 3.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

Review 4.  Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity.

Authors:  Juan P Cerliani; Sean R Stowell; Iván D Mascanfroni; Connie M Arthur; Richard D Cummings; Gabriel A Rabinovich
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

5.  Novel fluorescent glycan microarray strategy reveals ligands for galectins.

Authors:  Xuezheng Song; Baoyun Xia; Sean R Stowell; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Chem Biol       Date:  2009-01-30

6.  Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand.

Authors:  Mirian Mendoza; Dongli Lu; Angela Ballesteros; Sandra M Blois; Kelsey Abernathy; Chiguang Feng; Charles J Dimitroff; Jonathan Zmuda; Maria Panico; Anne Dell; Gerardo R Vasta; Stuart M Haslam; Gabriela Dveksler
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

7.  Microbial glycan microarrays define key features of host-microbial interactions.

Authors:  Sean R Stowell; Connie M Arthur; Ryan McBride; Oren Berger; Nahid Razi; Jamie Heimburg-Molinaro; Lilian C Rodrigues; Jean-Philippe Gourdine; Alexander J Noll; Stephan von Gunten; David F Smith; Yuriy A Knirel; James C Paulson; Richard D Cummings
Journal:  Nat Chem Biol       Date:  2014-05-11       Impact factor: 15.040

8.  The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells.

Authors:  Nathalie Jouve; Nicolas Despoix; Marion Espeli; Laurent Gauthier; Sophie Cypowyj; Karim Fallague; Claudine Schiff; Françoise Dignat-George; Frédéric Vély; Aurélie S Leroyer
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

9.  Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.

Authors:  Sean R Stowell; Connie M Arthur; Kristin A Slanina; John R Horton; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

10.  Functional characterization of an eosinophil-specific galectin, ovine galectin-14.

Authors:  Anna R Young; Garry J Barcham; Joanna M Kemp; Jillian L Dunphy; Andrew Nash; Els N Meeusen
Journal:  Glycoconj J       Date:  2008-09-23       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.